Elliott Wave View in Bausch Health (BHC) suggests the rally from June 4 low (20.28) unfolded as a 5 waves impulse Elliott Wave structure. Up from 20.28, wave (1) ended at 21.9 and wave (2) pullback ended at 20.8. The stock then resumes the rally higher in wave (3) towards 25.85, and wave (4) pullback ended at 24.61. Finally, the stock ended wave (5) of ((1)) at...
using EWT. EWT is great with counting the waves. To benefit from an accurate count, one must know how to use the wave count. I have used the EW as a tool to help me with my swing trading. I endeavor to buy calls at the end of wave 2 &4 (or beginning of wave 1,3&5) and exit my positions (take profits at the end of wave 1,3,&5 (or beginning of wave 2&4). I have been...
Diagonal. This Chart shows the three possible targets starting from the Fib 0.618 extension of wave 1-3, to the Top Rail of the Leading Diagonal , to the Target of the Cup n Handle. Please DYODD. I am holding Oct 19 $24 Calls which are currently over 100% up.
Good afternoon Traders,
BHC short-term Elliott wave analysis suggests that the pullback to $20.28 low ended black wave ((2)) pullback.
Up from there, it is in a possible 5 waves Elliott Wave structure higher. The first leg higher in black wave ((i)) ended at 09/13 peak (24.13). The internal structure of that move unfolded as a 5 wave impulse.
It ended blue...
Strong buy after MA 200 has come with insane violence. After a pull back of few days we have seen the start of a new uptrend. First TP is around 26,7 dollars where the gap down has left its trail.
As showed in the chart $BHC comes from a long bullish flag. Price is reaching the buy zone where the major bullish trendline goes through. It's not yet a buy but we are approching such zone. Strategy: watch and wait.
Extremely tight, and quiet range. In the mid point of a broadening pattern, looking for a move to upper end around 25 as a primary target. Bollinger bands on 30 min practically touching. Need some volume to get started
I am waiting for an entry long in $BHC but positive signs are already there especially RSI is giving an insight, MA 200 is almost close and it might be probable a new test. Monthly RSI is down and on a weekly basis price is approcing the pullback of the third bullish wave.
For the time being, given the positive earnings release a bullish trend continuation is...
Hello Traders,
In this Elliott Wave Analysis, we will have a look at the Bausch Health stock.
BHC ended the cycle from 03/01/18 (14.45) low at the peak of 06/13/18 (27.77) in black wave ((1)). Below from there the stock is currently correcting the cycle from 03/01/18 low in 3-7 or 11 swings in black wave ((2)) before more upside can be seen.
Near-term BHC ended...
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
BHC
